Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid

Tuesday, July 28, 2015

Israels Teva Pharmaceutical Industries will pay billion in cash and stock for Allergans generic drugs business solidifying Tevas position as the worlds No maker of generics while freeing Allergan to focus on branded drugs paying down debt and poten...

AstraZeneca sells rare cancer drug to Sanofi for up to $300 million

Tuesday, July 28, 2015

AstraZeneca AZNL under pressure from falling sales of older drugs is selling a medicine for a rare type of cancer to Sanofi SASYPA as it continues a drive to raise cash by divesting certain assets Sanofis rare diseases division Genzyme will pay Astr...

Teva in Talks to Buy Allergan’s Generic-Drug Unit

Monday, July 27, 2015

Israeli drug maker Teva Pharmaceutical Industries Ltd is in talks to combine with Allergan PLCs big genericdrug business in a move that would further consolidation in the healthcare industry and likely mean the end of Tevas pursuit of another acquisi...

JPMorgan to fund Lupin’s $880-million Gavis deal

Monday, July 27, 2015

JPMorgan will bankroll Lupin for its million acquisition of Gavis a New Jerseybased generic drug firm The Wall Street bank will act as guarantor till the date of payment which is some weeks away and then lend the full deal amount that Lupin will ha...

Allergan said to be exploring split into two businesses

Saturday, July 25, 2015

Allergan Plc is considering a breakup of the company into two businesses a person familiar with the matter told Reuters on Friday potentially adding the botoxmaker to a list of large drugmakers realigning themselves to focus on specific areas of thei...

India rejects Swiss drug maker Roche Patent claims on Valcyte again

Friday, July 24, 2015

Indian authorities have for the second time rejected Swiss drug maker Roches patent claims on valganciclovir or Valcyte used to treat an eye infection affecting acquired immune deficiency syndrome AIDS patients The Indian Patent Office in a ruling o...

Ra Pharmaceuticals announces $58.5M Series B Financing

Friday, July 24, 2015

Ra Pharmaceuticals today announced it has completed a million Series B financing coled by RA Capital Management Novo Ventures and Lightstone Ventures and joined by new investors Rock Springs Capital and Limulus Venture Partners All of the Companys e...

World's first malaria vaccine gets go-ahead from EU regulators

Friday, July 24, 2015

The worlds first malaria vaccine got a green light on Friday from European drugs regulators who recommended it should be licensed for use in babies in Africa at risk of the mosquitoborne disease The shot called RTSS or Mosquirix and developed by Bri...

Perrigo to acquire Leading German Dietary Supplement Brand Yokebe

Thursday, July 23, 2015

Perrigo Company plc today announced that it has entered into an agreement to acquire Naturwohl Pharma GmbH with its leading German dietary supplement brand Yokebe The brand is expected to generate approximately million in full year net sales Yokebe...

Roche readies new drugs in two-year window before copycats hit

Thursday, July 23, 2015

Switzerlands Roche is lining up more new drugs to drive sales in a twoyear window before cheap copycats of its biotech medicines hit the market including a promising cancer immunotherapy it hopes to launch by late The strategy is working so far wit...